Haymaker is a blank check company formed for the purpose of effecting a business combination, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses in the consumer and consumer-related products and services industries. Haymaker is led by Chief Executive Officer and Executive Chairman, Steven J. Heyer; President, Andrew R. Heyer; and Chief Financial Officer, Christopher Bradley.
Biote (NASDAQ: BTMD) utilizes the “Biote Method”, a comprehensive, end-to-end platform that provides Biote-certified practitioners with the training and certification needed to successfully provide solutions that optimize hormone levels on a patient-by-patient basis. Biote-certified practitioners deliver personalized hormone replacement therapy (“HRT”) to relieve the symptoms of hormonal imbalance as well as offer a complementary Biote-branded line of dietary supplements to customers. The Company recognizes revenues through the Biote-partnered clinics fees and from the sale of Biote-branded dietary supplements.